Table 4.
Incidence of events per cohort
Statistic | Ohasama | Finn-Home | Tsurugaya | Didima | Montevideo | Five cohorts |
---|---|---|---|---|---|---|
Number of subjects | 2777 | 2075 | 836 | 665 | 400 | 6753 |
Mean follow-up | 11.8 (4.0) | 7.9 (1.1) | 5.2 (1.0) | 7.8 (1.3) | 8.7 (1.5) | 9.2 (3.3) |
Total person-years | 32696 | 16431 | 4343 | 5164 | 3472 | 62106 |
Fatal events | ||||||
All | 551 | 143 | 77 | 72 | 9 | 852 |
Noncardiovascular | 349 | 100 | 51 | 31 | 5 | 536 |
Unknown cause | 1 | 0 | 3 | 1 | 0 | 5 |
Cardiovascular | 201 | 43 | 23 | 40 | 4 | 311 |
Stroke | 102 | 6 | 5 | 5 | 3 | 121 |
Ischemic heart disease | 46 | 30 | 9 | 9 | 0 | 94 |
Sudden death | 7 | 1 | 2 | 15 | 0 | 25 |
Heart failure | 24 | 0a | 4 | 11 | 1 | 40 |
Peripheral arterial disease | 6 | 3 | 3 | 0 | 0 | 12 |
Other cardiac deathb | 16 | 3 | 0 | 0 | 0 | 19 |
Nonfatal events | ||||||
Stroke | 227 | 45 | 44 | 8 | 2 | 326 |
Myocardial infarction | n.a. | 52 | 18 | 6 | 2 | n.a. |
Coronary revascularization | n.a. | 90 | n.a. | 3 | 8 | n.a. |
Heart failure | n.a. | 42 | n.a. | 2 | 3 | n.a. |
Pacemaker implantation | n.a. | n.a. | n.a. | 3 | n.a. | n.a. |
Fatal and nonfatal events | ||||||
All cardiovascularc | 384 | 207 | 71 | 61 | 17 | 740 |
Cardiac eventsd | 93 | 167 | 27 | 48 | 12 | 347 |
Coronary eventse | 53 | 137 | 24 | 32 | 9 | 255 |
Cerebrovascular eventsf | 300 | 45 | 46 | 13 | 5 | 409 |
Abbreviation: n.a., not available.
Heart failure deaths in Finland are classified according to the cause underlying heart failure.
Includes valvular disease (n=11), hypertensive heart disease (n=6), endocarditis (n=1) and ‘unspecified disorder of circulatory system’ (n=1).
Cardiovascular mortality plus stroke and cardiac events.
Coronary events, fatal and nonfatal heart failure, pacemaker implantation and other cardiac deaths.
Mortality from ischemic heart disease and sudden death, and incidence of myocardial infarction and coronary revascularization.
Fatal and nonfatal strokes. Composite events do not add up since they include only the first event.